Periodic Reporting for period 2 - i4KIDS-EUROPE (Inclusive and Interconnected Ecosystem to Boost Paediatric Innovation in Europe-i4KIDS-EUROPE)
Periodo di rendicontazione: 2024-01-15 al 2025-03-14
The project has focused on:
- Mapping the pediatric innovation landscape, with emphasis on needs and barriers in less advanced regions.
- Building a sustainable network and engagement strategies for key stakeholders.
- Strengthening capacity and knowledge through training and mentoring.
- Communicating results to attract interest and foster collaboration.
- Ensuring effective coordination and management.
The expected impact includes greater awareness, cross-border collaboration, and the development of targeted solutions, leading to better health outcomes and reduced inequalities. By aligning with the UN Convention on the Rights of the Child, i4KIDS-EUROPE aims at positioning children’s health as a priority, shaping a resilient, inclusive, and innovation-driven pediatric healthcare network across Europe.
The main activities and achievements include:
1 Pediatric Ecosystem Diagnosis
A comprehensive analysis of the pediatric innovation landscape through a survey of 134 stakeholders and 25 in-depth interviews. The resulting Situation Report identified barriers such as fragmented funding, regulatory hurdles, and limited market access.
Outcome: The report guided project strategy and informed policy recommendations.
2 Network Building & Stakeholder Engagement
The project built a network of over 4,000 innovators via the i4KIDS-EUROPE group on the EIT Health Innovators Platform.
Outcome: Strengthened cross-border collaboration and mutual learning among innovator regions.
3 Capacity Building & Training
Twelve Training Capsules were developed on key topics, attracting 1,000+ participants from 34 countries, alongside six webinars.
Outcome: Training resources and a mentorship network boosted the ecosystem’s technical and business capabilities.
4 Pediatric Innovation Days (PIDs)
Two PIDs were hosted in Warsaw (2023) and Riga (2024), with over 600 participants from 30 countries.
Outcome: PIDs became a reference event for pediatric innovation, with future editions planned in Barcelona (2025) and Helsinki (2026).
5 White Paper Development
The White Paper, consolidated findings from working groups and surveys, offering actionable policy recommendations. Co-developed by 40+ organizations and validated by experts from 15 countries, it was shared with EU institutions (e.g. EMA, EIT Health).
Outcome: Influenced EU-level policy dialogue on pediatric innovation.
6 Hospital Challenge
An open call targeted clinical needs in pediatric hospitals. Eleven startups pitched to 16 hospitals, with the winner receiving mentorship and pilot opportunities.
Outcome: Enabled real-world validation and supported market entry of pediatric solutions.
7 Strategic Collaborations
Partnerships with projects such as ADD4KIDS, C4C, i4KIDS4RARE, and Stanford Biodesign brought synergies in adoption, clinical research, and rare diseases.
Outcome: Expanded impact through knowledge exchange and aligned strategies across Europe and beyond.
Wider Socioeconomic Impact
By boosting access to pediatric innovation in underserved regions, the project addresses health inequities and supports EU goals of social inclusion. However, challenges still remain. First, a financially secured and sustainable network is essential to maintain the activities started in the framework of the project. Second, resources to continue the ongoing research and demonstration are essential to tackle the complex needs of paediatric healthcare, with further projects required to prove the potential, effectiveness and scalability of these innovations. To this regard, more funding and research and development is needed, with continued investment, awareness and lobbying for improved regulatory adaptation, and innovative market access strategies in Europe and global reach.